EcoDrugPlus

Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 5

Ensembl ID : ENSG00000075429
Gene: CACNG5
Gene Synonyms:
8 APIs:
7 Cross references
251 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 6

Ensembl ID : ENSG00000130433
Gene: CACNG6
Gene Synonyms:
8 APIs:
4 Enzyme and pathways 7 Cross references
248 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 7

Ensembl ID : ENSG00000105605
Gene: CACNG7
Gene Synonyms:
8 APIs:
4 Enzyme and pathways 7 Cross references
257 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 8

Ensembl ID : ENSG00000142408
Gene: CACNG8
Gene Synonyms:
8 APIs:
11 Enzyme and pathways 7 Cross references
243 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 A

Ensembl ID : ENSG00000141837
Gene: CACNA1A
Gene Synonyms: APCA,CACNL1A4,CAV2.1,EA2,FHM,HPCA,MHP,MHP1,SCA6
8 APIs:
6 Enzyme and pathways 9 Cross references
269 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 B

Ensembl ID : ENSG00000148408
Gene: CACNA1B
Gene Synonyms: CACNL1A5,CACNN,CAV2.2
14 APIs:
3 Enzyme and pathways 8 Cross references
284 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 C

Ensembl ID : ENSG00000151067
Gene: CACNA1C
Gene Synonyms: CACH2,CACN2,CACNL1A1,CAV1.2,CCHL1A1,LQT8,TS
32 APIs:
13 Enzyme and pathways 9 Cross references
212 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 D

Ensembl ID : ENSG00000157388
Gene: CACNA1D
Gene Synonyms: CACH3,CACN4,CACNL1A2,CAV1.3,CCHL1A2
32 APIs:
12 Enzyme and pathways 8 Cross references
280 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 E

Ensembl ID : ENSG00000198216
Gene: CACNA1E
Gene Synonyms: BII,CACH6,CACNL1A6,CAV2.3
8 APIs:
6 Enzyme and pathways 8 Cross references
295 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 F

Ensembl ID : ENSG00000102001
Gene: CACNA1F
Gene Synonyms: AIED,CAV1.4,CORDX3,CSNB2,CSNB2A,CSNBX2,JM8,JMC8,OA2
32 APIs:
8 Cross references
176 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 G

Ensembl ID : ENSG00000006283
Gene: CACNA1G
Gene Synonyms: CAV3.1,NBR13
8 APIs:
7 Enzyme and pathways 8 Cross references
198 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Calcium Voltage-Gated Channel Subunit Alpha1 H

Ensembl ID : ENSG00000196557
Gene: CACNA1H
Gene Synonyms: CAV3.2
9 APIs:
7 Enzyme and pathways 8 Cross references
213 Possible Orthologues:


Display Options: Drug type Mechanism of Action Route of Adminstration Status Therapeutic Area Therapeutic Indication

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).